Prevention of contrast induced-acute kidney injury using coenzyme Q10 in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Davoud AhmadimoghaddamSeyed Saman TalebiAyesheh RahmaniMaryam ZamanirafeErfan ParvanehAkram RanjbarJalal PoorolajalMaryam MehrpooyaPublished in: European journal of clinical pharmacology (2023)
The trial was registered at Iranian Registry of Clinical Trials ( https://www.irct.ir/trial/60435 , identifier code: IRCT20120215009014N414). Registration date: 2021-12-29.
Keyphrases
- st segment elevation myocardial infarction
- percutaneous coronary intervention
- clinical trial
- phase ii
- acute kidney injury
- phase iii
- st elevation myocardial infarction
- acute myocardial infarction
- acute coronary syndrome
- coronary artery disease
- study protocol
- antiplatelet therapy
- coronary artery bypass grafting
- cardiac surgery
- open label
- magnetic resonance
- coronary artery bypass
- high glucose
- atrial fibrillation
- randomized controlled trial
- diabetic rats
- computed tomography
- heart failure
- contrast enhanced
- placebo controlled